YAP1 and hepatocellular carcinoma: Interestingly, YAP1 expression rate in cHC-CCAs and cholangiolocellular IHCCAs was not so high as in EHBCAs, IHCCAs and CK19 (+) HCCs and was more similar to the expression levels seen in the CK19 (−) HCC group.